Removing The Barriers To Effective AAV Process Development With Next-Gen Analytical Platforms

Today’s bioprocess workflows demand more efficiency than ever before. This is driving the need for greater improvements in analytical assay performance and instrument automation. eXmoor Pharma Concepts' analytical team leader Dr. Kiren Baines, addresses the challenges around removing analytics as the bottleneck and sourcing the variability of analytical assays in AAV process development.

The development of next-generation analytical platforms has opened the door to improvements in assay throughput and reproducibility, providing researchers with more automated solutions for the assessment of viral vector identity, purity and stability. Discover how Dr. Baines uses these technologies to meet increased throughput and safety demands for scaling AAV process development.

Here is what you'll learn from this webinar:

• How next-generation analytical platforms are helping to solve key AAV process development challenges.
• How analytical automation is helping to drive greater throughput and reproducibility in today’s bioprocess workflows.
• How improvements in analytical assay performance are providing critical precision and efficiency advantages in AAV process development.
• How analytical instrument automation provides critical process and workflow advantages for scaling AAV process development.
• About overcoming today’s analytical challenges in AAV process development.